How many insider trades does FilingIQ track for EVMN?

FilingIQ tracks 82 Form 4 insider transactions for EVMN (Evommune, Inc.), covering filings from Nov 5, 2025 onwards. 9 of those were filed in the last 90 days.

Are EVMN insiders net buyers or net sellers?

Across the full Form 4 history for EVMN, 5 transactions (6%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does EVMN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is EVMN in?

Evommune, Inc. (EVMN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $983.55M.

EVMN insider trading

Healthcare

Evommune, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

6% / 0%

Market cap

$983.55M

About Evommune, Inc.

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.

Company website: www.evommune.com

EVMN insider activity at a glance

FilingIQ has scored 82 insider transactions for EVMN since Nov 5, 2025. The most recent filing in our index is dated Apr 16, 2026.

Across the full history, 5 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EVMN insider trades is 58.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live EVMN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for EVMN?: FilingIQ tracks 82 Form 4 insider transactions for EVMN (Evommune, Inc.), covering filings from Nov 5, 2025 onwards. 9 of those were filed in the last 90 days.
Are EVMN insiders net buyers or net sellers?: Across the full Form 4 history for EVMN, 5 transactions (6%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EVMN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is EVMN in?: Evommune, Inc. (EVMN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $983.55M.

Methodology & sources

Every EVMN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.